Disclosure of adverse clinical trial results--should legal immunity be granted to drug companies?
Vernillo
Anthony
A
New York University College of Dentistry. Oral & Maxillofacial Pathology, Radiology & Medicine, 345 East 24th Street, New York, NY 10010, USA. chart212@aol.com
D002986:Clinical Trials as Topic / Q000941:ethics* / Q000331:legislation & jurisprudence; D003657:Decision Making / Q000941:ethics; D004345:Drug Industry / Q000941:ethics / Q000331:legislation & jurisprudence*; D026689:Ethical Analysis; D006801:Humans; D007258:Informed Consent / Q000941:ethics*; D016365:Liability, Legal; D028681:Moral Obligations; D012108:Research Personnel; D035842:Research Subjects; D016896:Treatment Outcome; D014342:Truth Disclosure / Q000941:ethics*; D014481:United States